SCHEMBL32688274

SCHEMBL32688274

N#Cc1c(-c2cccc(N3CCCC3=O)c2)cc(=O)[nH]c1SCc1nnn[nH]1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BRD4 O60885 1/20 0.38
▸ BRDT Q58F21 1/20 0.38
▸ PARP1 P09874 3/20 0.36
▸ HSD11B1 P28845 6/20 0.35
▸ ALDH1A1 P00352 2/20 0.34
▸ HPGD P15428 2/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ CYP2D6 P10635 1/20 0.34
▸ CYP2C9 P11712 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ TBK1 Q9UHD2 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.32
▸ MEN1 O00255 2/20 0.32
▸ KMT2A Q03164 2/20 0.32
▸ GAA P10253 1/20 0.32
▸ ADORA3 P0DMS8 1/20 0.31
▸ ADORA2A P29274 1/20 0.31
▸ ADORA2B P29275 1/20 0.31
▸ ADORA1 P30542 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32688262 0.92 GRK6 (0.37) HSD11B1TBK1ADORA3ADORA2AADORA2B
SCHEMBL32688231 0.90 ALDH1A1 (0.36) HSD11B1ALDH1A1HPGDCYP3A4KDM4E
SCHEMBL32688472 0.88 GRK6 (0.36) HSD11B1ALDH1A1HPGDKDM4EMEN1
SCHEMBL32688310 0.87 GRK6 (0.37) HSD11B1ALDH1A1HPGDKDM4EMEN1
SCHEMBL32688199 0.85 HSD11B1 (0.36) PARP1HSD11B1ALDH1A1HPGDMEN1
SCHEMBL32688163 0.85 KISS1R (0.39) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL32688425 0.84 KISS1R (0.39) ALDH1A1
SCHEMBL32688223 0.82 KISS1R (0.35) HSD11B1ALDH1A1HPGDKDM4EKMT2A
SCHEMBL32687963 0.81 USP2 (0.37) ALDH1A1HPGDCYP1A2CYP3A4CYP2D6
SCHEMBL32687986 0.81 KMT2A (0.39) BRD4HSD11B1ALDH1A1HPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors ORSOBIO INC (US) 2026-03-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors CPT1B, CBR1, MUSK BRD4 3710/4885BRDT 913/4885PARP1 1626/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback